Are Biotech Stocks Overvalued and in a Bubble?
March 26 -- Clearbridge Investments Health Care Analyst Marshall Gordon discusses the performance of biotech stocks. Bloomberg’s Drew Armstrong also speaks on “Market Makers.”
Most Recent Videos
Full Show: What'd You Miss? (09/20)
54:10 - Guests include: Ohio Governor John Kasich. (Source: Bloomberg)